Welcome to the 2nd hybrid symposium of MCI Forum!
We are pleased to invite you to participate in the second hybrid symposium of the “Mild Cognitive Impairment Forum”, 13:00 – 18:00, October 6, 2023, at:
*****
Program
■Opening Remarks: 13:00 – 13:10
Ryosuke Takahashi MD, PhD
Kyoto University
■Special Session: New era of Alzheimer’s Disease control
Chair: Ryosuke Takahashi MD, PhD
Takeshi Iwatsubo MD, PhD
13:10 – 13:35
Most recent advances in the Diagnosis and Treatment of Alzheimer’s Disease
Michael Weiner MD, PhD
University of California San Francisco (UCSF), USA
>>> Click here for summary
13:35 – 13:55 Discussion
13:55 – 14:20
Disease modification of Alzheimer’s disease in MCI and preclinical stages
Takeshi Iwatsubo MD, PhD
Tokyo University
>>> Click here for summary
14:20 – 14:25 Discussion
14:25 – 14:40
Discussion & Designated speech: Concerns about Lecanemab use in routine practice for MCI & early AD
Masanori Fukushima MD, PhD
Learning Health Society Institute
>>> Click here for summary
14:40 – 15:05
Pivotal trial of low-intensity pulsed ultrasound therapy for Alzheimer’s disease
Hiroaki Shimokawa MD, PhD
International University of Health and Welfare
>>> Click here for summary
15:05 – 15:10 Discussion
15:10 – 15:35 General Discussion
■Session I: Cohort study for early detection of AD
Chair: Akira Kuzuya MD, PhD
Kyoto University
15:35 – 15:50
Chinese Preclinical Alzheimer’s Disease Study (C-PAS): Design and Preliminary Findings
Lin Huang MD, PhD
Shanghai Jiaotong University
>>> Click here for summary
15:50 – 16:05
Current Status and Challenges of MCI Diagnosis in the Dementia Kobe Model
Hisatomo Kowa MD, PhD
Kobe University
>>> Click here for summary
16:05 – 16:20
Differential risk of Alzheimer’s disease in MCIs with elevated PET Abeta
Bin Zhou MD, PhD
Learning Health Society Institute
>>> Click here for summary
16:20 – 16:35 Panel Discussion
16:35 – 16:45 Break
■Session II: Frontiers in Alzheimer’s Disease
Chair: Ayae Kinoshita MD, PhD
Bin Zhou MD, PhD
16:45 – 17:00
Neurovascular approach for mild cognitive impairment
Masafumi Ihara MD, PhD
National Cerebral and Cardiovascular Center (NCVC)
>>> Click here for summary
17:00 – 17:15
Gut microbiota in dementia with Lewy bodies
Kinji Ohno MD, PhD
Nagoya University
>>> Click here for summary
17:15 – 17:30
Towards novel biomarkers and potential therapeutic targets for Alzheimer’s disease as a “synaptopathy”
Akira Kuzuya MD, PhD
Kyoto University
>>> Click here for summary
17:30 – 17:45 Panel Discussion
Closing Remarks: 17:45 – 18:00
Bin Zhou MD, PhD